REMEGEN(09995),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

09995 REMEGEN

Closed 11-05 16:08:17

71.300

+1.050

+1.49%

High73.250	Low70.100	Vol2.98M
Open70.250	D1 Closing70.250	Amplitude4.48%
Mkt Cap40.19B	Tradable Cap14.87B	Total Shares563.61M
T/O213.85M	T/O Rate1.43%	Tradable Shares208.58M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"09995","market":"HK","secType":"STK","nameCN":"REMEGEN","latestPrice":71.3,"timestamp":1793866097008,"preClose":70.25,"halted":0,"volume":2984689,"delay":0,"changeRate":0.01494661921708181,"floatShares":208581239,"shares":563608243,"eps":1.5179179120284294,"marketStatus":"Closed","change":1.05,"latestTime":"11-05 16:08:17","open":70.25,"high":73.25,"low":70.1,"amount":213848311,"amplitude":0.04484,"askPrice":71.35,"askSize":3000,"bidPrice":71.3,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":13.6489154759047,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1793928600000},"marketStatusCode":5,"adr":0,"listingDate":1604851200000,"exchange":"SEHK","adjPreClose":70.25,"openAndCloseTimeList":[[1793842200000,1793851200000],[1793854800000,1793865600000]],"volumeRatio":1.122268,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688331","market":"SH","secType":"STK","nameCN":"Remegen Co.,Ltd.","latestPrice":97.21,"timestamp":1793862000000,"preClose":95.66,"halted":0,"volume":8091400,"delay":0,"premium":"-37.67"}},"requestUrl":"/m/hq/s/09995/tweets","defaultTab":"tweets","newsList":[{"id":"1139113646","title":"REMEGEN: BlackRock, Inc. Disposes of Shares, Long Position Falls to 4.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=1139113646","media":"HK Disclosure","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139113646?lang=en_us&edition=fundamental","pubTime":"2026-11-04 17:34","pubTimestamp":1793784854,"startTime":"0","endTime":"0","summary":"BlackRock, Inc. disposed of 1.38 million shares of REMEGEN off-exchange on October 30, 2026, with consideration in non-cash assets, not matched on the SEHK open market and therefore not a direct...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a44b570a4bc942c79569e09a943adc8c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189392525","title":"BOCOM International Keeps Buy Rating on RemeGen (09995), Trims Target Price to HK$128","url":"https://stock-news.laohu8.com/highlight/detail?id=1189392525","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189392525?lang=en_us&edition=fundamental","pubTime":"2026-11-04 14:24","pubTimestamp":1793773459,"startTime":"0","endTime":"0","summary":"BOCOM International has released a research report maintaining its \"Buy\" rating on RemeGen (09995), significantly raising its 2026 out-licensing revenue forecast, lifting its 2026 revenue estimate...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688331","BK1574","BK1583","LU2148510915.USD","09995","EWH","LU1969619763.USD","LU2328871848.SGD","LU2488822045.USD","LU1064130708.USD","BK1161","LU1064131003.USD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172056842","title":"RemeGen Shares Climb Over 6% in Early Trading; Plans A-Share Buyback of RMB 30 Million to RMB 60 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1172056842","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172056842?lang=en_us&edition=fundamental","pubTime":"2026-11-04 11:40","pubTimestamp":1793763622,"startTime":"0","endTime":"0","summary":"RemeGen Co., Ltd. (09995) climbed more than 6% in early trading, with the stock up 5.92% as of press time at HK$66.25, on turnover of HK$128.3 million.On November 2, RemeGen announced that its board...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064130708.USD","159982","09995","03188","LU1064131003.USD","LU2488822045.USD","82846","BK1610","02846","LU2328871848.SGD","LU1969619763.USD","BK1147","02843","BK1161","82823","BK1583","02822","03130","82822","83130","BK0239","LU2148510915.USD","BK1574","82843","688331","07233","02827","83188","02823","399300"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160113788","title":"Movement Alert｜REMEGEN Intraday Rise 5.52% in Regular Trading, second A-share buyback plan supports sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1160113788","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160113788?lang=en_us&edition=fundamental","pubTime":"2026-11-04 10:21","pubTimestamp":1793758871,"startTime":"0","endTime":"0","summary":"On November 4, REMEGEN recorded an Intraday Rise of 5.52% in Regular Trading, with shares trading at HK$65.95 and turnover of HK$65.66 million.The clearest catalyst in recent disclosures is the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"REMEGEN Soars on Second A-Share Buyback Plan","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165622028","title":"HK Movers | Biotech Shares Advance; BEONE MEDICINES Up Over 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165622028","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165622028?lang=en_us&edition=fundamental","pubTime":"2026-11-04 09:51","pubTimestamp":1793757104,"startTime":"0","endTime":"0","summary":"Hong Kong biotechnology stocks traded strongly, with $BEONE MEDICINES(06160)$ rising more than 6%. $WUXI BIO(02269)$, $AKESO(09926)$, $REMEGEN(09995)$ and $WUXI APPTEC(02359)$ each advanced over 4%, $ZAI LAB(09688)$ gained more than 3%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160","02269","09995","09926","02359","09688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163223517","title":"RemeGen Records Stable Share Base for October 2026, Affirms Public-Float Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1163223517","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163223517?lang=en_us&edition=fundamental","pubTime":"2026-11-03 17:02","pubTimestamp":1793696562,"startTime":"0","endTime":"0","summary":"RemeGen Co., Ltd. (H-share listing on HKEX; A-share listing on SSE) reported no changes in either its authorised or issued share capital during October 2026, according to the company’s latest Monthly...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125247987","title":"Hong Kong Stock Movers: Innovative Drug Concept Stocks Extend Losses, GENSCRIPT B-1K (01548) Plunges Over 15%, KEYMED BIO-B (02162) Drops Nearly 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1125247987","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125247987?lang=en_us&edition=fundamental","pubTime":"2026-11-03 14:50","pubTimestamp":1793688619,"startTime":"0","endTime":"0","summary":"Innovative drug concept stocks extended their declines, with GENSCRIPT B-1K (01548) falling 15.66% to HK$30.16, ASCLETIS-B (01672) dropping 7.68% to HK$4.39, REMEGEN (09995) declining 5.46% to...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162","HK0000306685.HKD","HK0000320264.USD","HK0000320223.HKD","LNGR","BK1583","BK4588","01548","BK1587","159992","HK0000306701.USD","BK1574","MEDX","BK1141","LU2328871848.SGD","IBBQ","01672","BK1515","09995","BK1161","LU1969619763.USD","BK1576","KCAI","BK4585","06978","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132257644","title":"Movement Alert｜REMEGEN falls 5.01% in Regular Trading, second A-share buyback this year fails to ease pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=1132257644","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132257644?lang=en_us&edition=fundamental","pubTime":"2026-11-03 13:18","pubTimestamp":1793683102,"startTime":"0","endTime":"0","summary":"On November 3, REMEGEN fell 5.01% in Regular Trading, trading at HK$62.5, with turnover of HK$85.97 million.The clearest catalyst in public disclosures is an event-driven update: the company...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"REMEGEN Drops on Second A-Share Buyback Announcement","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109702028","title":"RemeGen Plans A-Share Buyback Valued at 30 Million to 60 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1109702028","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109702028?lang=en_us&edition=fundamental","pubTime":"2026-11-02 17:02","pubTimestamp":1793610147,"startTime":"0","endTime":"0","summary":"RemeGen Co.,Ltd. (688331.SH) has announced that its board of directors has approved a proposal for a second share buyback in 2026 through centralized bidding transactions.The company intends to...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02843","83188","02846","83130","BK1610","LU2328871848.SGD","BK1583","LU2148510915.USD","02827","BK1161","159982","03188","399300","82846","LU1064131003.USD","688331","03130","LU1064130708.USD","BK1574","LU2488822045.USD","02822","02823","BK1147","07233","LU1969619763.USD","82823","BK0239","82843","82822","09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680271219","title":"Learn Why The Bull Case For RemeGen (SEHK:9995) Could Change Following Profit Turnaround","url":"https://stock-news.laohu8.com/highlight/detail?id=2680271219","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680271219?lang=en_us&edition=fundamental","pubTime":"2026-11-01 00:31","pubTimestamp":1793464285,"startTime":"0","endTime":"0","summary":"RemeGen reported earnings for the nine months to September 30, 2026, with revenue of CNY 6,763.78 million and net income of CNY 5,273.23 million, compared with a loss in the prior year period.\nThe swing from a net loss to basic earnings per share of CNY 9.41 indicates a significant change in operating performance and cost or mix efficiency.\nThis analysis will examine how RemeGen's investment narrative may be reshaped by this earnings turnaround and what it may signal for investors.\n\nScan how...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/learn-why-the-bull-case-for-remegen-sehk9995-could-change-fo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/learn-why-the-bull-case-for-remegen-sehk9995-could-change-fo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PMDE","RGLO","VGFPF","DECU","JOYT","FEBU","09995","BK1583","LU2328871848.SGD","LU1969619763.USD","BK1574","VOTE","GXDW","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679829048","title":"RemeGen (SEHK:9995) Stock Can Q3 Earnings Sustain Its Profit Rebound?","url":"https://stock-news.laohu8.com/highlight/detail?id=2679829048","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679829048?lang=en_us&edition=fundamental","pubTime":"2026-10-30 18:29","pubTimestamp":1793356181,"startTime":"0","endTime":"0","summary":"RemeGen came into this Q3 2026 print with a bargain label attached, trading on a P/E of 4.7x and sitting well below some valuation estimates. The fresh numbers tell a more complicated story. Management reported Q3 revenue of ¥910.5m and basic earnings per share of ¥1.09, a sharp comedown from the prior quarter’s outsized figures. The share price closed at HK$64.85 on 30 October, barely moved over the past week yet still down meaningfully over one and three months, which shows traders are...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/remegen-sehk9995-stock-can-q3-earnings-sustain-its-profit-re","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/remegen-sehk9995-stock-can-q3-earnings-sustain-its-profit-re","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PMDE","LU1969619763.USD","JOYT","09995","BK1161","RGLO","BK1574","GXDW","LU2328871848.SGD","VGFPF","DECU","BK1583","VOTE","FEBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169302979","title":"Movement Alert｜REMEGEN Intraday Rise 5.13% in Regular Trading, profit turnaround and AbbVie RC148 licensing deal supported shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1169302979","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169302979?lang=en_us&edition=fundamental","pubTime":"2026-10-30 13:03","pubTimestamp":1793336612,"startTime":"0","endTime":"0","summary":"On October 30, REMEGEN recorded an Intraday Rise of 5.13% in Regular Trading, trading at HK$66.5 with turnover of HK$97.298 million.The clearest catalyst was the company’s newly disclosed...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"REMEGEN Soars as Q3 Profit Reverses to RMB611M Net","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141294644","title":"RemeGen Jumps Over 3% in Morning Trading After Signing Exclusive Licensing Agreement with AbbVie for RC148","url":"https://stock-news.laohu8.com/highlight/detail?id=1141294644","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141294644?lang=en_us&edition=fundamental","pubTime":"2026-10-30 10:50","pubTimestamp":1793328638,"startTime":"0","endTime":"0","summary":"Hot topics section, watchlist stocks, data center, market center, capital flows, simulated trading client.RemeGen (09995) rose more than 3% intraday. As of press time, the stock was up 2.53% at...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","BK1161","LU2328871848.SGD","BK1574","LU1064130708.USD","BK1583","LU2488822045.USD","LU1064131003.USD","BK0239","LU2148510915.USD","688331","09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679840632","title":"RemeGen Returns to Profit in Q3; Revenue Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2679840632","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679840632?lang=en_us&edition=fundamental","pubTime":"2026-10-29 19:27","pubTimestamp":1793273244,"startTime":"0","endTime":"0","summary":"RemeGen  posted net profit attributable to shareholders of the listed company of 610.9 million yuan for the third quarter of 2026, compared with a loss a year earlier.Diluted earnings per share was 1.08 yuan, according to a Thursday Hong Kong bourse filing.For the three months ended Sept. 30, operating revenue at the biopharmaceutical company was 910.5 million yuan, up 46% year over year.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2148510915.USD","LU2328871848.SGD","LU1064130708.USD","LU2488822045.USD","09995","FCA","BK0239","BK1161","LU1064131003.USD","688331","BK1583","LU1969619763.USD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143052971","title":"RemeGen Reports 5.273 Billion Yuan Net Profit Attributable to Shareholders for First Three Quarters","url":"https://stock-news.laohu8.com/highlight/detail?id=1143052971","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143052971?lang=en_us&edition=fundamental","pubTime":"2026-10-29 19:22","pubTimestamp":1793272952,"startTime":"0","endTime":"0","summary":"RemeGen (09995) has released an announcement regarding its financial results for the first three quarters of 2026.During the period, the company recorded operating revenue of 6.764 billion yuan,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995","BK1583","BK1574","LU1064130708.USD","LU1064131003.USD","LU2148510915.USD","BK0239","LU1969619763.USD","688331","BK1161","LU2328871848.SGD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679267074","title":"RemeGen Chairman Gets Proposal to Buy Back Up to 60 Million Yuan of Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2679267074","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679267074?lang=en_us&edition=fundamental","pubTime":"2026-10-29 14:20","pubTimestamp":1793254807,"startTime":"0","endTime":"0","summary":"RemeGen  Chairman Wang Weidong received a proposal to buy back between 30 million yuan and 60 million yuan of shares, according to a Wednesday filing with the Shanghai bourse.The shares will be repurchased within three months.The biopharmaceutical company's Shanghai-listed shares fell 2% during recent trading on Thursday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRTO","FCA","09995","BK1161","LU2148510915.USD","LU2488822045.USD","LU2328871848.SGD","BK0239","LU1969619763.USD","BK1574","688331","LU1064131003.USD","LU1064130708.USD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101412739","title":"China's NMPA to Strengthen Policy Support for Traditional Chinese Medicine Sector; RemeGen H1 Revenue Jumps 433.11% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1101412739","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101412739?lang=en_us&edition=fundamental","pubTime":"2026-10-26 07:48","pubTimestamp":1792972124,"startTime":"0","endTime":"0","summary":"Ministry of Commerce Responds to U.S. Release of New Proposed Outbound Investment Restrictions: On October 23, the U.S. Treasury Department issued a new version of proposed rules on outbound...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01088","LU2148510915.USD","BK1505","KCAI","02506","BK1170","09995","BK1189","BK1617","BK0239","LU2488822045.USD","688331","BK1161","BK1240","BK1538","02384","BK4588","BK4585","LU1064130708.USD","LU1969619763.USD","LU1064131003.USD","LU2328871848.SGD","BK1178","02768","BK1110","BK1583","BK1574","VXUS","LU0287142896.SGD","LU0173614495.USD","BK1594"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116950383","title":"Movement Alert｜REMEGEN Falls 5.01% in Regular Trading, Earnings Window Nears Amid Biotechnology Sector Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=1116950383","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116950383?lang=en_us&edition=fundamental","pubTime":"2026-10-22 11:48","pubTimestamp":1792640890,"startTime":"0","endTime":"0","summary":"On October 22, REMEGEN fell 5.01% in Regular Trading, trading at HK$63.5, with turnover of HK$56.78 million.The most recent disclosed catalyst is that the company plans to review and approve its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"REMEGEN Slides as Pre-Earnings Review Looms on Oct 29","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131607020","title":"RemeGen Sets 29 October 2026 Board Meeting to Approve Q3 and 9-Month 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1131607020","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131607020?lang=en_us&edition=fundamental","pubTime":"2026-10-16 16:44","pubTimestamp":1792140252,"startTime":"0","endTime":"0","summary":"RemeGen Co., Ltd. has scheduled a board meeting for 29 October 2026 to review and approve the unaudited financial results for the third quarter and the nine months ended 30 September 2026. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129997446","title":"Movement Alert｜REMEGEN falls 5.03% in Regular Trading, after disclosing RMB370 million purchase of SPD Bank wealth products","url":"https://stock-news.laohu8.com/highlight/detail?id=1129997446","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129997446?lang=en_us&edition=fundamental","pubTime":"2026-10-15 13:26","pubTimestamp":1792041982,"startTime":"0","endTime":"0","summary":"On October 15, REMEGEN fell 5.03% in regular trading, trading at HK$63.35, with turnover of HK$133 million.The latest disclosed catalyst is the company’s announcement that it signed two wealth...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"REMEGEN drops on RMB370M wealth product purchase disclosure","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0917},{"period":"1month","weight":-0.0277},{"period":"3month","weight":-0.1164},{"period":"6month","weight":-0.281},{"period":"1year","weight":-0.228},{"period":"ytd","weight":-0.0243}],"compareEarnings":[{"period":"1week","weight":0.0357},{"period":"1month","weight":-0.005},{"period":"3month","weight":-0.0631},{"period":"6month","weight":-0.0937},{"period":"1year","weight":-0.0783},{"period":"ytd","weight":-0.0668}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"RemeGen Co Ltd is a China-based company principally engaged in biopharmaceutical research, biopharmaceutical service, biopharmaceutical production and sale. The Company focuses on therapeutic antibody drugs such as antibody-drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and bispecific antibodies. The Company’s main products include telitacicept, disitamab vedotin, RC28-E and others. The Company's products are mainly used to treat major diseases such as autoimmune diseases, oncology and ophthalmology. The Company mainly operates its businesses in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.110172},{"month":2,"riseRate":0.666667,"avgChangeRate":0.167223},{"month":3,"riseRate":0.5,"avgChangeRate":0.012545},{"month":4,"riseRate":0.833333,"avgChangeRate":0.095268},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.049233},{"month":6,"riseRate":0.666667,"avgChangeRate":0.089626},{"month":7,"riseRate":0.666667,"avgChangeRate":-0.010221},{"month":8,"riseRate":0.333333,"avgChangeRate":0.055035},{"month":9,"riseRate":0.5,"avgChangeRate":0.07525},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.003277},{"month":11,"riseRate":1,"avgChangeRate":0.046168},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.053467}],"exchange":"SEHK","name":"REMEGEN","nameEN":"REMEGEN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"REMEGEN(09995),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest REMEGEN(09995) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"REMEGEN,09995,REMEGEN股票,REMEGEN股票老虎,REMEGEN股票老虎国际,REMEGEN行情,REMEGEN股票行情,REMEGEN股价,REMEGEN股市,REMEGEN股票价格,REMEGEN股票交易,REMEGEN股票购买,REMEGEN股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"REMEGEN(09995),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest REMEGEN(09995) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}